Diagnostics stocks

We cover 21 companies grouped under the Diagnostics theme. The median market value in the group is $1.82B. Across the group, the median move over the past trading day is −0.70%. 76% of the 21 with a 200-day average trade above it. Price change over the past year runs from −30.1% to +225.5% across the middle 80 percent of the group, with a median of +11.1%. Across the group, 1 company currently carries a tier A volume signal.